Manulife Financial Corp (MFC)
(Delayed Data from NYSE)
$25.90 USD
-0.10 (-0.38%)
Updated Jul 29, 2024 04:00 PM ET
After-Market: $25.90 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
A Value C Growth C Momentum B VGM
Manulife Financial (MFC) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$28.52 | $30.66 | $25.71 | 9.69% |
Price Target
Based on short-term price targets offered by 11 analysts, the average price target for Manulife Financial comes to $28.52. The forecasts range from a low of $25.71 to a high of $30.66. The average price target represents an increase of 9.69% from the last closing price of $26.00.
Analyst Price Targets (11)
Broker Rating
Manulife Financial currently has an average brokerage recommendation (ABR) of 1.75 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 12 brokerage firms. The current ABR compares to an ABR of 1.75 a month ago based on 12 recommendations.
Of the 12 recommendations deriving the current ABR, six are Strong Buy and three are Buy. Strong Buy and Buy respectively account for 50% and 25% of all recommendations. A month ago, Strong Buy made up 50%, while Buy represented 25%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 6 | 6 | 6 | 6 | 5 |
Buy | 3 | 3 | 3 | 3 | 3 |
Hold | 3 | 3 | 3 | 3 | 4 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.75 | 1.75 | 1.75 | 1.75 | 1.92 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
7/24/2024 | Cormark Securities | Lemar Persaud | Moderate Buy | Moderate Buy |
6/27/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
5/10/2024 | CIBC World Markets Corp. | Paul D Holden | Hold | Hold |
5/9/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
5/9/2024 | TD Securities | Mario Mendonca | Strong Buy | Strong Buy |
5/8/2024 | National Bank Financial | Gabrial Dechaine | Hold | Strong Buy |
4/8/2024 | BMO Capital Markets | Thomas Mackinnon | Strong Buy | Strong Buy |
3/26/2024 | Not Identified | Not Identified | Moderate Buy | Moderate Buy |
2/16/2024 | Desjardins Securities | Doug Young | Moderate Buy | Moderate Buy |
2/16/2024 | Scotiabank | Meny Grauman | Strong Buy | Strong Buy |
1/23/2024 | Evercore Partners | Thomas Gallagher | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.75 |
ABR (Last week) | 1.75 |
# of Recs in ABR | 12 |
Average Target Price | $28.52 |
LT Growth Rate | 10.00% |
Industry | Insurance - Life Insurance |
Industry Rank by ABR | 101 of 252 |
Current Quarter EPS Est: | 0.64 |